Analysts See $0.47 EPS for HCP, Inc. (HCP)

January 23, 2018 - By Stephen Andrade

 Analysts See $0.47 EPS for HCP, Inc. (HCP)
Investors sentiment decreased to 0.85 in Q3 2017. Its down 0.38, from 1.23 in 2017Q2. It fall, as 54 investors sold HCP, Inc. shares while 188 reduced holdings. 43 funds opened positions while 163 raised stakes. 411.39 million shares or 0.00% less from 411.39 million shares in 2017Q2 were reported.
Goldman Sachs Grp invested 0.07% in HCP, Inc. (NYSE:HCP). Fernwood Invest Ltd Liability reported 0.27% stake. Cibc Mkts Corporation stated it has 68,314 shares. Essex Financial Serv reported 12,580 shares. Natixis holds 0.04% of its portfolio in HCP, Inc. (NYSE:HCP) for 141,028 shares. Lpl Ltd Liability Com, California-based fund reported 87,249 shares. Tower Bridge Advisors holds 0.03% of its portfolio in HCP, Inc. (NYSE:HCP) for 8,074 shares. Pacad Inv Limited has 26,899 shares. Maryland Capital stated it has 0.05% of its portfolio in HCP, Inc. (NYSE:HCP). Cetera Advisor Networks Ltd holds 0.01% or 11,743 shares in its portfolio. 113,407 were accumulated by Hartford Inv Mngmt. 26,113 are owned by Investment Centers Of America. 34,907 were reported by Norinchukin State Bank The. Fagan Associate owns 33,900 shares or 0.47% of their US portfolio. S R Schill And has invested 0.13% of its portfolio in HCP, Inc. (NYSE:HCP).

Analysts expect HCP, Inc. (NYSE:HCP) to report $0.47 EPS on February, 12.They anticipate $0.12 EPS change or 20.34 % from last quarter’s $0.59 EPS. HCP’s profit would be $222.36 million giving it 12.58 P/E if the $0.47 EPS is correct. After having $0.48 EPS previously, HCP, Inc.’s analysts see -2.08 % EPS growth. The stock increased 0.98% or $0.23 during the last trading session, reaching $23.65. About 3.71 million shares traded. HCP, Inc. (NYSE:HCP) has risen 8.01% since January 23, 2017 and is uptrending. It has underperformed by 8.69% the S&P500.

HCP, Inc. (NYSE:HCP) Ratings Coverage

Among 20 analysts covering HCP (NYSE:HCP), 5 have Buy rating, 1 Sell and 14 Hold. Therefore 25% are positive. HCP had 70 analyst reports since September 8, 2015 according to SRatingsIntel. The company was maintained on Friday, September 15 by KeyBanc Capital Markets. The rating was downgraded by Stifel Nicolaus on Thursday, February 11 to “Sell”. As per Monday, September 21, the company rating was downgraded by Goldman Sachs. The firm has “Hold” rating given on Monday, May 15 by Jefferies. Stifel Nicolaus maintained HCP, Inc. (NYSE:HCP) rating on Sunday, August 20. Stifel Nicolaus has “Hold” rating and $30.0 target. JP Morgan maintained the stock with “Neutral” rating in Tuesday, March 15 report. Evercore maintained HCP, Inc. (NYSE:HCP) on Tuesday, September 8 with “Hold” rating. Mizuho upgraded the shares of HCP in report on Thursday, November 2 to “Buy” rating. Morgan Stanley upgraded HCP, Inc. (NYSE:HCP) on Monday, March 20 to “Equal-Weight” rating. The stock has “Hold” rating by Jefferies on Monday, June 12.

HCP, Inc. is a fully integrated real estate investment trust that invests primarily in real estate serving the healthcare industry in the United States. The company has market cap of $11.19 billion. HCP owns a large-scale portfolio diversified across multiple sectors, led by senior housing, life science and medical office. It has a 20.91 P/E ratio. Recognized as a global leader in sustainability, HCP has been a publicly-traded firm since 1985 and was the first healthcare REIT selected to the S&P 500 index.

More news for HCP, Inc. (NYSE:HCP) were recently published by:, which released: “Is HCP, Inc. a Buy?” on January 18, 2018.‘s article titled: “Lanny’s Recent Stock Purchase – HCP, Inc.” and published on December 25, 2017 is yet another important article.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: